Default company panoramic image

Sentio, LLC

Sentio's smart-sensor technology will become the standard of care in surgeries requiring safe, fast & effective nerve mapping and avoidance.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Southfield, MI, USA
  • Currency USD
  • Founded July 2007
  • Employees 12
  • Website

Company Summary

Sentio is a technology-driven medical device company, specializing in proprietary smart-sensor nerve mapping systems. Nerve injury is a serious risk during minimally invasive surgery. Sentio has pioneered a novel technology for providing real-time surgeon feedback of precise nerve location as a means to avoid injury and improve patient outcomes, ultimately resulting in a solution that is safer, faster and easier to use than traditional techniques


  • Default avatar
    Stephen Bartol
    President and CEO

    Stephen Bartol, MD, MBA is President, CEO and Co-Founder of the Company. Dr. Bartol is
    responsible for identifying and managing the Company’s strategic objectives, maintaining
    surgeon relationships and a surgeon driven Company culture, as well as allocating capital and
    resources to areas consistent with the strategic objectives of the Company.

  • Default avatar
    Christopher Wybo
    Chief Operating Officer, VP R&D

    Christopher Wybo is the COO, Vice President of Research & Development and a Co-Founder of the Company. He began to devote full-time attention to the Company in January 2008 and has since been responsible for the management of SentioMMG development, intellectual property and regulatory submissions, as well as day-to-day operations of the Company.

  • Default avatar
    Michael Wider
    Chief Scientific Officer

    Dr. Wider serves as Chief Science Officer, where he is responsible for leading the scientific programs and clinical trials at Sentio, while working closely with the surgeon advisory board to direct research activities that promote a greater understanding of the science behind Sentio’s products.

  • Default avatar
    Aashish Shah
    Director of Product Development

    Aashish Shah is the Director of Product Development. Mr. Shah joined the Company in June
    2010 to enhance the Design and Development process in preparation for market entry into
    Canada and Europe. He brings with him an extensive mix of product development expertise
    intertwined with today's regulatory requirements and quality system initiatives.

  • Default avatar
    Michael Sherman
    Senior Product Manager

    Mike is responsible for sales and marketing of the Sentio MMG product to surgeons. He is largely responsible for building surgeon and distributor relationships that drive product adoption in the marketplace. Mike works with hospital purchasing groups to achieve vendor approval and negotiate pricing.

  • Default avatar
    Rebecca Wendela
    Director of Clinical Support

    Ms. Wendela has over nine years of experience in the field of intraoperative neural monitoring and received her CNIM certificate in 2002. She has monitored over 2,200 surgical cases and is responsible for directing the Sentio technical support team. Rebecca has been largely responsible for developing the surgeon and sales training curriculum and works alongside the Sentio sales team to promote surgeon adoption.

  • Default avatar
    Richard Soltis
    Manager, Purchasing and Supplier Quality

    Mr. Soltis is responsible for managing the flow of material from suppliers to Sentio, including pricing, quality, sourcing, cost reductions and on-time delivery. He is responsible for establishing supplier control measures and overseeing the quality of the Sentio supply base, including contract manufacturers. He is responsible for generating and evaluating supplier quality data to ensure product quality.

  • Default avatar
    Daniel Backing

    Mr. Backing is responsible for the accounting operations of Sentio, to include the production of periodic financial reports, maintenance of an adequate system of accounting records, and a comprehensive set of controls and budgets designed to mitigate risk, enhance the accuracy of the company's reported financial results, and ensure that reported results comply with GAAP or international financial reporting standards.

  • Default avatar
    Jason Hines
    Quality Manager

    Mr. Hines rovides leadership and oversight for quality management, quality systems, quality control, complaint investigation and closure, CAPA management, and documentation functions. He is responsible for ensuring compliance with all FDA and ISO requirements and maintaining efficiency in the process. He supports and proposes product quality improvement activities and projects that may enhance the performance of Sentio products or systems.


  • Default avatar
    David Parsigian with Honigman Miller Schwartz and Cohn LLP
    Default avatar
    Jeffrey Reilly with RJ Miller

Previous Investors

  • Default avatar
    Ann Arbor SPARK
    Default avatar
    Friends & Family